Question 1

How big is the Global Lyme Disease Diagnostics market?

Accepted Answer

According to Value Market Research, the Global Lyme Disease Diagnostics market size was estimated at USD 1.05 Billion in 2025 and is expected to reach USD 1.11 Billion in 2026.

Question 2

What is the Global Lyme Disease Diagnostics market growth?

Accepted Answer

The Global Lyme Disease Diagnostics market is expected to grow at a CAGR of 5.57% from 2026-2034 to reach USD 1.71 Billion by 2034.

Question 3

Which country holds the highest share in the Global Lyme Disease Diagnostics market?

Accepted Answer

North America held the highest share in the Global Lyme Disease Diagnostics market.

Question 4

How is the Global Lyme Disease Diagnostics market segmented in the report?

Accepted Answer

The Global Lyme Disease Diagnostics market is segmented By Diagnostic Technology (Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining), By End User (Hospitals, Clinical Laboratories, Others).

Question 5

Who are the key players in the Global Lyme Disease Diagnostics market?

Accepted Answer

Some key players include Abbott, Bio-Rad Laboratories Inc., Covance Inc., F. Hoffmann-La Roche AG and T2 Biosystems Inc.

Question 6

What are the factors driving the lyme disease diagnostics market?

Accepted Answer

Key drivers include the rising incidence of Lyme disease globally, increasing awareness about early diagnosis, advancements in molecular and serological testing technologies, growing government surveillance programs, and expanding healthcare infrastructure supporting infectious disease detection and monitoring.

Question 7

Which segment accounted for the largest lyme disease diagnostics market share?

Accepted Answer

Serological Tests dominated the market with a share of 54.75% in 2025, driven by their widespread clinical adoption, high sensitivity in detecting Lyme antibodies, cost-effectiveness, and strong recommendation in diagnostic guidelines for initial screening and confirmation.